NASHVILLE, Tenn.--(BUSINESS WIRE)--Diagnovus, LLC, a molecular diagnostic company focused on underserved, aggressive and lesser-known diseases, has entered into a license agreement with Cincinnati Children’s Hospital Medical Center to commercialize the first genomic assay to help physicians diagnose and treat eosinophilic esophagitis (EoE), a debilitating inflammatory condition.
Help employers find you! Check out all the jobs and post your resume.
